ATHERONOVA
AtheroNova, through its wholly-owned subsidiary, AtheroNova Operations, Inc., is a development stage company currently researching novel patents-pending applications of certain natural compounds to regress atherosclerotic plaque deposits, a process called delipidization. The company is entering into a research agreement for its second laboratory animal study at the Cedars-Sinai Heart Institute's Division of Cardiology in conjunction with a major university to validate the findings of its initial study and prepare for human trials. The Company plans to develop multiple applications for its compounds, to be used in pharmaceutical grade products for the treatment of atherosclerosis.
ATHERONOVA
Industry:
Biotechnology Pharmaceutical
Founded:
2006-01-01
Address:
Irvine, California, United States
Country:
United States
Website Url:
http://www.atheronova.com
Total Employee:
1+
Status:
Active
Contact:
19494761122
Email Addresses:
[email protected]
Total Funding:
2.41 M USD
Technology used in webpage:
Apache Mobile Non Scaleable Content PHP CPanel SAKURA Internet
Similar Organizations
Avid Radiopharmaceuticals
Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Advisors List
Current Employees Featured
Stock Details
Official Site Inspections
http://www.atheronova.com
- Host name: www26269u.sakura.ne.jp
- IP address: 49.212.15.63
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
